StressHYPNOSTRESSNCT05760014
Medical Hypnosis and Stress Reduction in Hospitalization
An observational study of Stress, run by University Hospital, Lille at 1 site in France.
Trial summary
Patients with chronic diseases, especially rare diseases with uncertain diagnoses, have a representation of their disease and an experience of their hospitalization that is sometimes traumatic, distressing and painful. Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Stress
- How many people
- 24 participants
- Where
- 1 siteFrance
- Study dates
- 28 Mar 2023to 9 Feb 2024
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Study population: Patients hospitalised for their chronic illness
Who may be able to join
- Patients hospitalised in the internal medicine department of the Lille University Hospital
- Age>= 18 years
- Patients having expressed their non opposition
Who cannot join
- Not covered by the social security system
- Person unable to receive informed information
- Persons deprived of liberty
- Persons under legal protection (guardianship / curatorship)
- Psychotic and/or dementia disorders
- Pregnant and breastfeeding women
Trial locations and contacts
1 site in 1 country.
About this study
Official title: Interest of Medical Hypnosis in Reducing Stress and Improving the Experience of Hospitalization in Internal Medicine
Patients with chronic diseases, especially rare diseases with uncertain diagnoses, have a representation of their disease and an experience of their hospitalization that is sometimes traumatic, distressing and painful. Patients hospitalized can benefit from non-medicinal techniques, such as medical hypnosis, which could improve the perceived stress in these patients and thus optimize the hospitalization experience. The aim of this study is to evaluate the impact of medical hypnosis in reducing stress and improving the experience of hospitalization comparing two groups : a group (cases) benefiting from an hypnotic technic " the place of safety " and a control group without intervention during hospitalization
- Conditions
- Stress
- Keywords
- hypnosis, perceived stress, place of safety, case control study
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
| Study group | Role | What they receive |
|---|---|---|
| CAS patients | CAS patients with a conventional follow-up who will benefit from the hypnosis technique known as "Place of Safety" on their admission to conventional hospitalization. | |
| TEMOINS patients | TEMOINS patients with conventional follow-up who will not benefit from the medical hypnosis technique. |
What is being measured
The primary outcome is the main question the study is designed to answer.
STAI questionnaire dimension STAI completed at discharge.
STAI-ETAT
Measured: At discharge, an average 10 days
Secondary outcomes (6)
The STAI ETAT (the current emotional state) questionnaire
State Trait Anxiety Inventory Etat - Trait (40 questions - each item has a score from 1 to 4 (4 being the highest level of anxiety))
Measured: at baseline and at discharge, an average 10 days
The STAI-TRAIT (the usual emotional state ) questionnaire
State-Trait Anxiety Inventory (STAI-TRAIT) SCORE: 20 items in the form of a 4-response Likert scale (from 1 : low anxiety to 4 : highest anxiety). The score goes from 20 to 80 depending of the degree of anxiety
Measured: at baseline and at discharge, an average 10 days
patient opinion questionnaire
Measured: At discharge, an average 10 days
The difference in STAI STATUS score between the questionnaire completed post-hypnotic treatment and the questionnaire at admission
Measured: At discharge, an average 10 days
The ordinal severity scale correlated with the STAI ETAT questionnaire score;
Measured: At discharge, an average 10 days
Self-rated stress scale correlated with the STAI ETAT questionnaire score.
Measured: At discharge, an average 10 days
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted8 Mar 2023
- Study start28 Mar 2023
- Primary completion9 Feb 2024
- Study completion9 Feb 2024
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for StressStudies of the same condition, open and under way.
- More trials run by University Hospital, LilleThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Case-control
- Time perspective
- Prospective
- Enrolment
- 24 participants (actual)
Sponsor and investigators
- Lead sponsor
- University Hospital, Lille
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
- Investigators
- Mereym-Maud FAHRAT, MD, Principal investigator, University Hospital, Lille
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT05760014
- Sponsor's protocol ID
- 2022_0670
- Other IDs
- 2022-A02406-37
- Acronym
- HYPNOSTRESS
- Status last verified
- Dec 2025
- First submitted
- 24 Feb 2023
- Last updated
- 26 Dec 2025
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
Study at a glance
From the registry record, last updated by the sponsor on 26 Dec 2025. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Interest of Medical Hypnosis in Reducing Stress and Improving the Experience of Hospitalization in Internal Medicine
- ClinicalTrials.gov ID
- NCT05760014
- Acronym / sponsor ID
- HYPNOSTRESS / 2022_0670
- Conditions
- Stress
- Keywords
- hypnosis, perceived stress, place of safety, case control study
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 24 participants (actual)
- Lead sponsor
- University Hospital, LilleUniversity, hospital or other
- Study start
- 28 Mar 2023 (actual)
- Primary completion
- 9 Feb 2024 (actual)
- Study completion
- 9 Feb 2024 (actual)
- First posted
- 8 Mar 2023 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Patients with chronic diseases, especially rare diseases with uncertain diagnoses, have a representation of their disease and an experience of their hospitalization that is sometimes traumatic, distressing and painful. Patients hospitalized can benefit from non-medicinal techniques, such as medical hypnosis, which could improve the perceived stress in these patients and thus optimize the hospitalization experience. The aim of this study is to evaluate the impact of medical hypnosis in reducing stress and improving the experience of hospitalization comparing two groups : a group (cases) benefiting from an hypnotic technic " the place of safety " and a control group without intervention during hospitalization
Study design
- Observational model
- Case-control
- Time perspective
- Prospective
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| CAS patients | – | –CAS patients with a conventional follow-up who will benefit from the hypnosis technique known as "Place of Safety" on their admission to conventional hospitalization. |
| TEMOINS patients | – | –TEMOINS patients with conventional follow-up who will not benefit from the medical hypnosis technique. |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
- Study population
- Patients hospitalised for their chronic illness
Key inclusion criteria (3 listed)
- Patients hospitalised in the internal medicine department of the Lille University Hospital
- Age>= 18 years
- Patients having expressed their non opposition
Key exclusion criteria (6 listed)
- Not covered by the social security system
- Person unable to receive informed information
- Persons deprived of liberty
- Persons under legal protection (guardianship / curatorship)
- Psychotic and/or dementia disorders
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
STAI questionnaire dimension STAI completed at discharge.
Time frame: At discharge, an average 10 days
STAI-ETAT
6 secondary outcomes
The STAI ETAT (the current emotional state) questionnaire
Time frame: at baseline and at discharge, an average 10 days
The STAI-TRAIT (the usual emotional state ) questionnaire
Time frame: at baseline and at discharge, an average 10 days
patient opinion questionnaire
Time frame: At discharge, an average 10 days
The difference in STAI STATUS score between the questionnaire completed post-hypnotic treatment and the questionnaire at admission
Time frame: At discharge, an average 10 days
The ordinal severity scale correlated with the STAI ETAT questionnaire score;
Time frame: At discharge, an average 10 days
Self-rated stress scale correlated with the STAI ETAT questionnaire score.
Time frame: At discharge, an average 10 days
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 26 Dec 2025.
Related trials for Stress
Not yet recruiting
Effect of Stress Ball Use During Femoral Arterial Sheath Removal After Coronary Angiography
Femoral Arterial Sheath Removal, Stress Ball
Recruiting
Effect of a Brief Daily Digital Meditation on Well-Being in US Young Adults (BEGIN II)
Mental Health and General Well-being
Not yet recruitingObservational study
Periodontal Status and Biomarkers in MASLD
Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
Recruiting
NightWare and Cardiovascular Health in Women With PTSD
Post Traumatic Stress Disorder, Cardiovascular Diseases
Active, not recruiting
Intervention to Address Disparate Mental Health Consequences of COVID-19 Pandemic on Latinx and African Newcomers
Mental Health Issue, Mental Health Disorder
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Mereym-Maud FAHRAT, MD principal investigator
University Hospital, Lille
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Stress, run by University Hospital, Lille at 1 site in France.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 3 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 26 Dec 2025. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
STAI questionnaire dimension STAI completed at discharge. (time frame: At discharge, an average 10 days). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 26 Dec 2025.